A simple and sensitive validated HPLC method for quantitative determination of cisplatin in human plasma
暂无分享,去创建一个
[1] K. Devarakonda,et al. Population pharmacokinetics of cisplatin in Asian Indian cancer patients , 2009 .
[2] P. D. Williams. The application of renal cells in culture in studying drug-induced nephrotoxicity , 1989, In Vitro Cellular & Developmental Biology.
[3] A. El‐Yazigi,et al. Pharmacokinetics of Platinum in Cancer Patients Treated with Carboplatin in Combination with High-Dose Methotrexate , 1989, Pharmaceutical Research.
[4] I. Olver,et al. Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma , 2004, Cancer Chemotherapy and Pharmacology.
[5] L. Zufía,et al. Simple and rapid determination of carboplatin in plasma by high-performance liquid chromatography. Error pattern and application to clinical pharmacokinetic studies. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[6] L. Cattel,et al. A preliminary pharmacokinetic study of docetaxel, carboplatin and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck. , 2001, Farmaco.
[7] E. Walker,et al. Evolution of chemotherapy with platinum compounds. , 1999, Annals of clinical and laboratory science.
[8] J. Verweij,et al. Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations , 1996, Cancer Chemotherapy and Pharmacology.
[9] R. Kizu,et al. A sensitive postcolumn derivatization/UV detection system for HPLC determination of antitumor divalent and quadrivalent platinum complexes. , 1995, Chemical & pharmaceutical bulletin.
[10] I. Wilson,et al. Drug Determination in Therapeutic and Forensic Contexts , 2012, Methodological Surveys in Biochemistry and Analysis.
[11] L. Davis,et al. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies , 1984, Cancer.
[12] R. Safirstein,et al. Uptake and metabolism of cisplatin by rat kidney. , 1984, Kidney international.
[13] Z. Siddik,et al. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. , 1984, Cancer research.
[14] K. Marsh,et al. Post-column reaction detector for platinum(II) antineoplastic agents. , 1984, Analytical chemistry.
[15] R. W. Frei,et al. Analysis of platinum complexes by liquid chromatogrphy with quenched phosphrescence detection , 1984 .
[16] Z. Siddik,et al. HPLC Analysis of Cisplatin Analogues in Biological Fluids , 1984 .
[17] M. Weiner,et al. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. , 1980, The Journal of pharmacology and experimental therapeutics.
[18] R. Gralla,et al. Comparison of methods of evaluating nephrotoxicity of cis‐platinum , 1980, Clinical pharmacology and therapeutics.